Observational multicentre prospective study to assess changes in cognitive function in patients treated with PCSK9i. Study protocol

• Main Authors: José Seijas-Amigo (Author), Diego Rodríguez-Penas (Author), Ana Estany-Gestal (Author), Pedro Suárez-Artime (Author), María Santamaría-Cadavid (Author), José Ramón González-Juanatey (Author)
• Format: Book
• Published: Elsevier, 2021-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<p><strong>Objective:</strong> PCSK9 inhibitors have been shown to reduce LDLc by up to about 60% and 85% when used with high doses of statins and ezetimibe (2019 ESC/EAS Guidelines). These therapies may lead to very low levels of LDLc and have been associated with possible cogniti...